drugset
drugset / Trial / NCT03930212

Progesterone Supplementation in Threatened Abortion

NCT03930212 ↗

Phase 4 Completed 190 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

To decide whether progesterone supplementation in threatened abortion is a sound practice.

Timeline

Start
2018-01-01
Primary completion
2018-12-31
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 400 mg Rectal

Indications

pregnancy disorder progesterone resistance